SCHEMBL7185860

SCHEMBL7185860

CCCc1cc(/C=C/C(=O)c2ccc(NC)cc2)c(OC)cc1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 2/20 0.59
PTPN1 P18031 7/20 0.50
DPP4 P27487 4/20 0.50
MEN1 O00255 2/20 0.50
LMNA P02545 2/20 0.50
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
GAA P10253 1/20 0.50
CTSL P07711 2/20 0.49
CTSB P07858 2/20 0.49
MITF O75030 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HTT P42858 1/20 0.48
PAX8 Q06710 1/20 0.48
ATM Q13315 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
CAPN1 P07384 1/20 0.48
SNCA P37840 1/20 0.48
TNFRSF1A P19438 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7185865 1.00 ABCG2 (0.59) ABCG2PTPN1DPP4MEN1LMNA
SCHEMBL7185666 0.91 PTPN1 (0.59) ABCG2PTPN1DPP4SNCA
SCHEMBL7185669 0.91 PTPN1 (0.59) ABCG2PTPN1DPP4SNCA
SCHEMBL7185993 0.88 MAPT (0.46) ABCG2PTPN1DPP4MEN1LMNA
SCHEMBL7185989 0.88 MAPT (0.46) ABCG2PTPN1DPP4MEN1LMNA
SCHEMBL7190844 0.87 DPP4 (0.66) ABCG2PTPN1DPP4CTSLCTSB
SCHEMBL9241073 0.87 TNFRSF1A (0.64) ABCG2PTPN1DPP4LMNAMAPT
SCHEMBL7190838 0.87 DPP4 (0.66) ABCG2PTPN1DPP4CTSLCTSB
SCHEMBL9241078 0.87 TNFRSF1A (0.64) ABCG2PTPN1DPP4LMNAMAPT
SCHEMBL7191428 0.87 DPP4 (0.46) ABCG2PTPN1DPP4MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed